Issue of Equity

11 November 2011

Phorm, Inc.

("Phorm" or the "Company")

Completion of Placing and Redemption of Convertible Loan Notes

Further to the announcements of 21 October and 4 November 2011, Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is pleased to announce that it has completed the £33.6m equity placing with institutional and other investors undertaken through Mirabaud Securities LLP.

As previously notified, the £16.075m convertible loan notes issued on 21 March 2011 will be redeemed today and the relevant shares have now been admitted to trading on AIM.

Enquiries:

Phorm, Inc

Andy Croxson (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

Brokers

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Adviser)

Andrew Chubb/Simon Bridges

Mirabaud Securities LLP +44 20 321 2508

(Joint Broker)

Peter Krens

Evolution Securities Limited +44 20 7071 4300

(Joint Broker)

Stuart Andrews

About Phorm:

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in Bucharest, Seoul, Sao Paolo and London.

The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com